Introduction
Ependymomas belong to a histologically, biologically and clinically heterogeneous group of rare glial tumours that show histological features of ependymal differentiation and are preferentially located in the cerebral ventricles or in the spinal cord. In total, ependymomas account for 6.8% of all gliomas, with the relative frequency being higher in children than in adults. 1 In adults, ependymomas account for less than 4% of primary central nervous system tumours 2 and are found more often in spinal (46%) than infratentorial (35%) or supratentorial (19%) locations. 3 These tumours are classified by the World Health Organization (WHO) in new guidelines and divided into three grades. 4 Ependymomas are characterised by such marked structural heterogeneity that in the same lesion it is possible to observe calcified, necrotic and cystic areas. Evident anaplastic features are observed in only 5% of cases. 5 Relatively frequent are locoregional recurrences, especially when surgery is not radical. Extracranial metastases, with involvement of lung, pleura and lymph nodes, have been described in isolated works of the literature. [6] [7] [8] [9] [10] [11] We report the case of a supratentorial anaplastic ependymoma with metastases to the spine, liver and lymph node presenting less than one year from clinical onset.
Case report
A healthy 65-year-old woman suddenly presented with drowsiness of unknown origin, accompanied by gradually increasing fatigue, inability to maintain the upright posture, headache, nausea and vomiting. Thorough neurological examination also revealed the presence of mild brachial crural hemiparesis, ocular convergence deficit, tremor and involuntary movement in the right hemisoma, presence of Babinski sign at the right side and absence of urinary sphincter control. Non-enhanced computed tomography (CT), performed in the emergency department (Figure 1(a) ), showed a hypodense and heterogeneous mass in the temporoparietal region, adjacent to the occipital horn of the lateral ventricle associated with significant midline deviation. Magnetic resonance imaging (MRI) study performed in May 2010 documented intra-axial brain lesion adjacent to the left lateral trigone, characterised by some cysts and infiltrating aspect of periventricular white matter (Figure 1 (b, c and d)). Two days later, the patient underwent transcranial resection. The bioptic examination was diagnostic for ependymoma with extensive areas of necrosis and a high proliferative index: the mass was positive for Ki-67 in approximately 40% of the cells. At that time the Institute of Pathology of our hospital, taking into account the histology of the tumour biopsy, classified it according to the guidelines of WHO 2007 as anaplastic ependymoma, 12 and now confirmed as anaplastic ependymoma grade III according the guidelines of WHO 2016. (The specimen was characterised by hypercellularity, cellular and nuclear pleomorphism, frequent mitosis, pseudopalisading necrosis, endothelial proliferation and perivascular rosettes.) Unfortunately in our case the prototypic fusion genes were not investigated, and therefore it was not possible to verify the molecular subgrouping. 13 The only researched tumour immune-phenotype according to the internal guidelines of our pathologist was: GFAP (þ), S100 (þ), CD99 (þ), D2-40 (þ) and EMA (þ). Focal positivity for cytokeratin AE1/AE3 and complete negativity for CK7, CK20 and P53 were observed.
Post-surgical CT and MRI performed with sequences before and after the administration of contrast gadolinium media showed reduction of midline deviation and normal postoperative outcomes ( Figure 2 ). The postoperative course was uneventful until discharge and the patient refused any type of adjuvant therapy. In July 2010, MRI of brain and spine showed meningeal enhancement of coatings at the site of surgical access (Figure 3(a-d) ), no metastases of the dural sac and the spine nor neoplastic cells in the cerebrospinal fluid (Figure 3 (e-i and l)). In the presence of recurrence the patient accepted and was submitted to brain radiation therapy (RT) until September (5940 cGy in 33 fractions). Radiation therapy was never suspended, in the absence of side effects. Findings of previous and subsequent MRI of the brain were overlapping (Figure 4(a-c) ), but MRI examination extended to the spine evaluation documented in pre and post-contrastographic sequences numerous focal abnormalities in the vertebral bodies of C3, D2, D5-D7, D9-D11, L1 and L3-L5 (Figure 4(d-i) ).
In December 2010, a new CT scan was performed, which showed an area of marked hypodensities at the level of the left cerebellar cortex associated with swelling, suggestive of local recurrence, confirmed after the administration of iodinated contrast media ( Figure 5(c  and d) ). In the remaining supratentorial regions, the findings appeared unchanged compared to the previous findings. Numerous focal liver lesions of repetitive nature in the II, III, IV, V and VII segments ( Figure  5(a and b) ) and involvement of several thoracic lymph nodes were also observed. Multiple osteoblastic vertebral lesions and involvement of pelvic bones were found ( Figure 5(e) ). A few days later, the tumour markers were CA-125 ¼ 73.3 IU/ml; NSE ¼ 110, 7 mg/L. There were no signs of pulmonary lesions. Vertebral biopsy confirmed the ependymal nature of the observed lesions. The patient died from infectious complications three weeks after staging ( Figure 6 ).
Discussion
Ependymomas mostly present benign characteristics. They show a tendency to recur at the primary site or, through the cerebrospinal fluid, along the surface of the spinal cord. Preoperative brain and spine MRI is the first choice examination to detect possible spinal involvement. [14] [15] [16] The local recurrence rate depends on the degree of radical surgery and RT, 2 which is often not applicable due to frequent intraoperative bleedings. Ependymoma growth rate is quite slow. This tumour metastasises outside the central nervous system only in very exceptional cases, 8 so far quantified in adulthood as 5% of all studied cases. 10 As described in the new 2016 World Health Organization Classification of Tumors of the Central Nervous System, 4 more than two-thirds of supratentorial ependymomas contain oncogenic fusions between RELA, the principal effector of nuclear factor kB (NF-kB) signalling and an uncharacterised gene, C11orf95. C11orf95-RELA fusions resulted from chromothripsis involving chromosome 11q13.1. C11orf95-RELA fusion proteins translocated spontaneously to the nucleus to activate NF-kB target genes, and rapidly transformed neural stem cells to form this tumour. Unfortunately, in our case it was not possible to verify the molecular subgrouping. Ependymomas have MRI characteristics of iso-hyperintensity on the sequences with long TR, and post-gadolinium sequences show an inhomogeneous enhancement referable to their structural heterogeneity. In the paediatric age, the subtentorial localisation poses the need for a differential diagnosis with medulloblastomas: ependymomas do not have restricted diffusion and spectroscopy shows an increased Cho/NAA ratio, less pronounced than in medulloblastoma; moreover, ependymomas originate from the floor of the fourth ventricle, whereas medulloblastomas originate from the cerebellar vermis, and project into the fourth ventricle. Ependymomas are more commonly infratentorial (60%), particularly in the fourth ventricle, and in 50% of cases can extend into the subarachnoid space of the cisterna magna or the cerebello-pontine angle, or involve the medulla and upper cervical cord. The second most common location is the spinal cord, followed by the lateral ventricles and the third ventricle. Approximately half of supratentorial ependymomas are parenchymal and half are primarily intraventricular, arising more often (75%) in the lateral ventricles than in the third ventricle. 1 Their biological behaviour is heterogeneous: the very few cases described in the literature present variable local recurrence rates and variable latency times before extracranial metastases appear.
Several authors suggest that metastases occur in cases of particular forms of gene expression determining cell surface molecules not always detected 14 and surgical manipulation while there are no correlations with the histological characteristics of the primary tumor. 8 The time of the clinical-radiological appearance of metastatic disease, in 80% of observed cases there was a primary tumor progression, although there are documented cases of metastatic evidence after decades from the initial disease and in absence of local recurrence. 8 Our case presents some unique characteristics: the extracranial metastases were observed shortly after the clinical onset of the primary disease. The vertebral lesions were radiographically evident after only a few months, which is in contrast with the low biological aggressiveness of the tumour. Finally, to our knowledge, it has never been described in the literature that a tumour spread repetitions in bone, liver and lymph nodes in the absence of lung metastases.
